Enhanced allograft survival and modulation of T-cell alloreactivity induced by inhibition of MMP/ADAM enzymatic activity

American Journal of Transplantation

Volumn 8, Issue 3, 2008, Pages 507-516

  Eaton, V L ^a   Lerret, N M ^a   Velasquez Lopera M M ^a,b   John, R ^a   Caicedo, M ^a   DeCresce, R P ^a   Jaramillo, A ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSIDAD DE ANTIOQUIA   (Colombia)

Author keywords

Acute allograft rejection; ADAM; Adamalysin; Chemokines; Chemotaxis; Cytokines; Immune modulation; Inflammation; Matrix metalloproteinase; Mouse; T cell immunity and transplantation; Therapeutics

Indexed keywords

ADAM PROTEIN; CHEMOKINE; CYTOKINE; DISINTEGRIN; DOXYCYCLINE; GELATINASE A; GELATINASE B; GROWTH FACTOR; ILOMASTAT; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE INHIBITOR;

ALLOGRAFT; ALLOIMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL INFILTRATION; CHEMOTAXIS; CONTROLLED STUDY; ENZYME DEFICIENCY; ENZYME INHIBITION; GRAFT SURVIVAL; HEART GRAFT; IMMUNOREACTIVITY; IN VITRO STUDY; MACROPHAGE ACTIVATION; MALE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ADAM PROTEINS; ANIMALS; CHEMOKINES; CHEMOTAXIS; COLLAGEN; CYTOKINES; DIPEPTIDES; DOXYCYCLINE; GELATINASES; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LEUKOCYTES, MONONUCLEAR; MALE; MICE; MICE, INBRED STRAINS; PROTEASE INHIBITORS; T-LYMPHOCYTES;

EID: 39749201514     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2007.02097.x     Document Type: Article

References (37)

1. Nagase H, Woessner JF, Jr. Matrix metalloproteinases. J Biol Chem 1999 274 : 21491 21494.
2. Shapiro SD, Senior RM. Matrix metalloproteinases. Matrix degradation and more. Am J Respir Cell Mol Biol 1999 20 : 1100 1102.
3. Sternlicht MD, Werb Z. How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 2001 17 : 463 516.
4. McCawley LJ, Matrisian LM. Matrix metalloproteinases: they're not just for matrix anymore! Curr Opin Cell Biol 2001 13 : 534 540.
5. Stone AL, Kroeger M, Sang QX. Structure-function analysis of the ADAM family of disintegrin-like and metalloproteinase-containing proteins. J Protein Chem 1999 18 : 447 465.
6. Seals DF, Courtneidge SA. The ADAMs family of metalloprotenases: multidomain proteins with multiple functions. Genes Dev 2003 17 : 7 30.
7. Garton KJ, Gough PJ, Raines EW. Emerging roles for ectodomain shedding in the regulation of inflammatory responses. J Leukoc Biol 2006 79 : 1105 1116.
8. Graesser D, Mahooti S, Haas T, Davis S, Clark RB, Madri JA. The interrelationship of α4 integrin and matrix metalloproteinase-2 in the pathogenesis of experimental autoimmune encephalomyelitis. Lab Invest 1998 78 : 1445 1458.
9. Graesser D, Mahooti S, Madri JA. Distinct roles for matrix metalloproteinase-2 and α4 integrin in autoimmune T cell extravasation and residency in brain parenchyma during experimental autoimmune encephalomyelitis. J Neuroimmunol 2000 109 : 121 131.
10. Ksontini R, Colagiovanni DB, Josephs MD et al. Disparate role for TNF-α and Fas ligand in concanavalin-A induced hepatitis. J Immunol 1998 160 : 4082 4089.
11. Leib SL, Leppert D, Clements J, Tauber MG. Matrix metalloproteinases contribute to brain damage in experimental pneumococcal meningitis. Infect Immun 2000 68 : 615 620.
12. Meli DN, Coimbra RS, Erhart DG et al. Doxycycline reduces mortality and injury to the brain and cochlea in experimental pneumococcal meningitis. Infect Immun 2006 74 : 3890 3896.
13. Yamachika S, Brayer J, Oxford GE, Peck AB, Humphreys-Beher MG. Aberrant proteolytic digestion of biglycan and decorin by saliva and exocrine gland lysates from the NOD mouse model for autoimmune exocrinopathy. Clin Exp Rheumatol 2000 18 : 233 240.
14. Pyo R, Lee JK, Shipley JM et al. Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms. J Clin Invest 2000 105 : 1641 1649.
15. Greenwald RA, Moak SA, Ramamurthy NS, Golub LM. Tetracyclines suppress matrix metalloproteinase activity in adjuvant arthritis and in combination with flurbiprofen, ameliorate bone damage. J Rheumatol 1992 19 : 927 938.
16. Suzuki J, Isobe M, Kawauchi M, Endoh M, Amano J, Takamoto S. Altered expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in acutely rejected myocardium and coronary arteriosclerosis in cardiac allografts of nonhuman primates. Transpl Immunol 2000 13 : 106 113.
17. Tsukioka K, Suzuki J, Kawauchi M et al. Expression of membrane-type 1 matrix metalloproteinase in coronary vessels of allotransplanted primate hearts. J Heart Lung Transplant 2000 19 : 1193 1198.
18. Ermolli M, Schumacher M, Lods N, Hammoud M, Marti HP. Differential expression of MMP-2/MMP-9 and potential benefit of an MMP inhibitor in experimental acute kidney allograft rejection. Transpl Immunol 2003 11 : 137 145.
19. Laplante A, Liu D, Demeule M et al. Modulation of matrix gelatinases and metalloproteinase-activating process in acute kidney rejection. Transpl Int 2003 16 : 262 269.
20. Rodrigo E, Lopez-Hoyos M, Escallada R et al. Circulating levels of matrix metalloproteinases MMP-3 and MMP-2 in renal transplant recipients with chronic transplant nephropathy. Nephrol Dial Transplant 2000 15 : 2041 2045.
21. Yamani MH, Starling RC, Young JB et al. Acute vascular rejection is associated with up-regulation of vitronectin receptor (αvβ3), increased expression of tissue factor, and activation of the extracellular matrix metalloproteinase induction system. J Heart Lung Transplant 2002 21 : 983 989.
22. Luckow B, Joergensen J, Chilla S et al. Reduced intragraft mRNA expression of matrix metalloproteinases Mmp3, Mmp12, Mmp13 and Adam8, and diminished transplant arteriosclerosis in Ccr5-deficient mice. Eur J Immunol 2004 34 : 2568 2578.
23. Ulinski T, Charpentier A, Colombat M et al. From humoral rejection to generalized thrombotic microangiopathy-role of acquired ADAMTS13 deficiency in a renal allograft recipient. Am J Transplant 2006 6 : 3030 3036.
24. Melenhorst WB, Van Den Heuvel MC, Stegeman CA et al. Upregulation of ADAM19 in chronic allograft nephropathy. Am J Transplant 2006 6 : 1673 1681.
25. Berthier CC, Lods N, Joosten SA et al. Differential regulation of metzincins in experimental chronic renal allograft rejection: Potential markers and novel therapeutic targets. Kidney Int 2006 69 : 358 368.
26. Campbell LG, Ramachandran S, Liu W et al. Different roles for matrix metalloproteinase-2 and matrix metalloproteinase-9 in the pathogenesis of cardiac allograft rejection. Am J Transplant 2005 5 : 517 528.
27. Fernandez FG, Campbell LG, Liu W et al. Inhibition of obliterative airway disease development in murine tracheal allografts by matrix metalloproteinase-9 deficiency. Am J Transplant 2005 5 : 671 683.
28. Corry RJ, Winn HJ, Russell PS. Primarily vascularized allografts of hearts in mice. The role of H-2D, H-2K, and non-H-2 antigens in rejection. Transplantation 1973 16 : 343 350.
29. Ratzinger G, Stoitzner P, Ebner S et al. Matrix metalloproteinases 9 and 2 are necessary for the migration of Langerhans cells and dermal dendritic cells from human and murine skin. J Immunol 2002 168 : 4361 4371.
30. Sitia G, Isogawa M, Iannacone M, Campbell IL, Chisari FV, Guidotti LG. MMPs are required for recruitment of antigen-nonspecific mononuclear cells into the liver by CTLs. J Clin Invest 2004 113 : 1158 1167.
31. Abel S, Hundhausen C, Mentlein R et al. The transmembrane CXC-chemokine ligand 16 is induced by IFN-gamma and TNF-alpha and shed by the activity of the disintegrin-like metalloproteinase ADAM10. J Immunol 2004 172 : 6362 6372.
32. Hundhausen C, Schulte A, Schulz B et al. Regulated shedding of transmembrane chemokines by the disintegrin and metalloproteinase 10 facilitates detachment of adherent leukocytes. J Immunol 2007 178 : 8064 8072.
33. Kajita M, Itoh Y, Chiba T et al. Membrane-type 1 matrix metalloproteinase cleaves CD44 and promotes cell migration. J Cell Biol 2001 153 : 893 904.
34. Kumagai K, Ohno I, Okada S et al. Inhibition of matrix metalloproteinases prevents allergen-induced airway inflammation in a murine model of asthma. J Immunol 1999 162 : 4212 4219.
35. McMillan SJ, Kearley J, Campbell JD et al. Matrix metalloproteinase-9 deficiency results in enhanced allergen-induced airway inflammation. J Immunol 2004 172 : 2586 2594.
36. Wang M, Qin X, Mudgett JS, Ferguson TA, Senior RM, Welgus HG. Matrix metalloproteinase deficiencies affect contact hypersensitivity: stromelysin-1 deficiency prevents the response and gelatinase B deficiency prolongs the response. Proc Nat Acad Sci (USA) 1999 96 : 6885 6889.
37. Gaow, Faia KL, Cszmadia V et al. Beneficial effects of targeting CCR5 in allograft recipients. Transplantation 2001 72 : 1199 1205.